Porter Stacey L.'s Form 4 filing
Outset Medical, Inc. (OM) · filed Feb 16, 2023
- Accession no.
- 0001484612-23-000023
- Filed
- Feb 16, 2023
- Trade date
- Feb 16, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $15.3K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Porter Stacey L.CIK 0001889204 | Officer (Chief People Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2023 | Common Stock | SSaleDisposed | −482 | $24.36 | −$11,741.52 | 64,053 | Direct | |
| Feb 16, 2023 | Common Stock | SSaleDisposed | −112 | $24.36 | −$2,728.32 | 63,941 | Direct | |
| Feb 16, 2023 | Common Stock | SSaleDisposed | −33 | $24.37 | −$804.21 | 63,908 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.